Vanda Pharmaceuticals | Capital De Empréstimo





Capital De Empréstimo Alterar Data
Acadia Pharmaceuticals USD 0 0 2025-03
Agios Pharmaceuticals USD 1.06M 0 2022-09
Akebia Therapeutics USD 47.64M 579K 2025-09
Alnylam Pharmaceuticals USD 1.04B 13.75M 2025-09
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 538.1M 323.22M 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Eli Lilly USD 40.87B 6.69B 2025-09
Enanta Pharmaceuticals USD 0 0 2024-12
Esperion Therapeutics USD 262.48M 235.95M 2024-06
Halozyme Therapeutics USD 800.07M 709.03M 2025-09
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 539.72M 21.23M 2025-09
J&J USD 39.41B 173M 2025-09
Lexicon Pharmaceuticals USD 56.11M 2.54M 2025-06
Ligand Pharmaceuticals USD 445.49M 445.44M 2025-09
Merck USD 39.97B 6B 2025-09
Minerva Neurosciences USD 0 86.58M 2024-09
Moderna USD 26M 6M 2025-09
Novartis USD 24.24B 174M 2025-09
Pfizer USD 57.41B 93M 2025-09
PTC Therapeutics USD 1.84B 298.68M 2025-09
Puma Biotechnology USD 10.87M 222K 2025-06
Sangamo BioSciences USD 0 0 2022-06
Sanofi EUR 15.72B 2.45B 2025-12
Takeda JPY 4.27T 81.29B 2025-12
Teva Pharmaceutical Industries USD 14.99B 1.78B 2025-12
Ultragenyx Pharmaceutical USD 782.75M 11.3M 2025-06
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Veracyte USD 0 0 2025-03


Vanda Pharmaceuticals Capital De Empréstimo - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.